Dr. Xing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Medical Oncology and Therapeutics Research
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-218-8233
Education & Training
Methodist Hospital (Houston)Fellowship, Hematology and Medical Oncology, 2015 - 2017
Mount Auburn HospitalResidency, Internal Medicine, 2012 - 2015
Sun Yat-Sen University of Medical ScienceClass of 1994
Certifications & Licensure
CA State Medical License 2018 - 2026
TX State Medical License 2017 - 2025
MA State Medical License 2012 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers Start of enrollment: 2019 Apr 15
Publications & Presentations
PubMed
- 71 citationsConditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysisYan Xing, George J. Chang, Chung Yuan Hu, Robert L. Askew, Merrick I. Ross
Cancer. 2010-05-01 - 20 citationsDevelopment and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection.Daniel A. Anaya, Janice N. Cormier, Yan Xing, Paul Koller, Lindsay Gaido
Annals of Surgery. 2012-01-01 - 115 citationsRecurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus MitotaneElizabeth G. Grubbs, Glenda G. Callender, Yan Xing, Nancy D. Perrier, Douglas B. Evans
Annals of Surgical Oncology. 2010-01-01
Press Mentions
Defence to Perform Final AccuTOXTM Preclinical Study Before Phase I Cancer TrialMarch 29th, 2023- Defence to Complete a Final Pre-Clinical Study Prior to Ind Filings for the Accutoxtm Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research InstituteMarch 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
